CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma

Gastric cardia adenocarcinoma (GCA) is the most aggressive subtype of gastric cancer with a high metastatic rate. In this report, we collected tumor tissue samples from 214 GCA cases and examined expression of CYR61, a target gene product of the Hippo-YAP/TAZ pathway, in the GCA tumors by immunohist...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jing, Yu, Guanzhen, Shao, Genbao, Sun, Aiqin, Chen, Miao, Yang, Wannian, Lin, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058739/
https://www.ncbi.nlm.nih.gov/pubmed/27105510
http://dx.doi.org/10.18632/oncotarget.8845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058739/
https://www.ncbi.nlm.nih.gov/pubmed/27105510
http://dx.doi.org/10.18632/oncotarget.8845

Ejemplares similares